首页> 外文期刊>Acta biochimica Polonica >Cytotoxicity of anticancer aziridinyl-substituted benzoquinones in primary mice splenocytes
【24h】

Cytotoxicity of anticancer aziridinyl-substituted benzoquinones in primary mice splenocytes

机译:抗癌性氮丙啶基取代的苯醌对原代小鼠脾细胞的细胞毒性

获取原文
获取外文期刊封面目录资料

摘要

The anticancer activity of aziridinyl-quinones is mainly attributed to their NAD(P)H:quinone oxidoreductase 1 (NQO1)-catalyzed two-electron reduction into DNA-alkylating products. However, little is known about their cytotoxicity in primary cells, which may be important in understanding their side effects. We found that the cytotoxicity of aziridinyl-unsubstituted quinones (n = 12) in mice splenocytes with a low amount of NQO1, 4 nmol × mg-1 × min-1, was caused mainly by the oxidative stress. Aziridinyl-benzoquinones (n = 6) including a novel anticancer agent RH1 were more cytotoxic than aziridinyl-unsubstituted ones with the similar redox properties, and their cytotoxicity was not decreased by an inhibitor of NQO1, dicumarol. The possible reasons for their enhanced cytotoxicity are discussed.
机译:氮丙啶基醌的抗癌活性主要归因于其NAD(P)H:醌氧化还原酶1(NQO1)催化的两电子还原成DNA烷基化产物。然而,关于它们在原代细胞中的细胞毒性知之甚少,这对于理解其副作用可能很重要。我们发现在少量NQO1、4 nmol×mg -1 ×min -1 的小鼠脾细胞中,叠氮基未取代醌(n = 12)具有细胞毒性。主要是由氧化应激引起的。包含新型抗癌剂RH1的丙啶基-苯醌(n = 6)比具有类似氧化还原特性的未经rid丙啶基的未取代的ones唑啉基-苯醌具有更高的细胞毒性,并且它们的细胞毒性不会被NQO1抑制剂双嘧洛尔所降低。讨论了其细胞毒性增强的可能原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号